Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You should start up a biopharma called Sugar Pills LLC and try submitting an IND and protocol. It's about your business style and you could shove tens of billions of shares on the market and abscond with the funds.
Leronlimab effects some of the same body responses as cortisol but with a completely different method. Cortisol needs to be finely balanced. Too much cortisol and you have an impaired immune system. Too little cortisol and you have increased inflammation. With leronlimab you have both a boosted immune system and decreased inflammation.
Would the FDA approve an IND and drug trial for the coronavirus if they knew the drug was useless for that indication?
RBNW is no longer a dumpster fire. Now the whole building is in flames.
Over there do they call you Captain? You're certainly going down with the ship.
There should be a PR today for IND and protocol submission for COVID-19.
Cytodyn's potential revenue for COVID-19 (coronavirus)
Both Taiwan and China want large amounts of leronlimab when it's proven to work with COVID-19.
With the large batch production that the CEO mentioned Samsung's cost to manufacture shouldn't be more than $25 per 700mg, the wholesale should be less than $100.
Overseas we might have a deal like Vyera with COGs +10% and 50% net sales. I would expect overseas retail to be around $600 per 700mg ($2400 total for coronavirus).
600,000 vials x $600 = $360,000,000 - 30% overhead = $252,000,000 / 2 = $144,000,000 - $25,200,000 (10% royalty net sales) = $118,800,000.
With Samsung using four bioreactors of 20 Kl capacity they should be able to produce 800,000 doses every two weeks.
After losing so much elsewhere he can't afford shares.
Cytodyn's Leronlimab and 100+ diseases
I've seen doubts expressed about leronlimab's ability to work in such a wide variety of diseases. One of the key things leronlimab does as a CCR5 inhibitor is to block the RANTES chemokine (CCL5). Why is that important?
It's better to be in Cytodyn for the big jumps.
He speaks the truth on twitter? Well at least some of the time. He is after all touting Cytodyn.
You have no clue whether those bankruptcies were personal or business. Since it mentions him by name rather than an attached business it's more likely they were personal. The timing of at least one of them is most likely tied to his divorce.
What were those companies? How do you know the nature of those bankruptcies.
Strange, I only see 736,000 traded at those times at .0022.
I thought all the longs here were buying up cheap shares. Zero volume now. Is it going to be another one of those two hour zero volume days where shares can't be given away.
The author is right some of the time.
How many times have you mentioned the number of PR releases? Sooner or later you'll surpass the number of PRs. broken record